The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.
Patients With Irritable Bowel Syndrome Are Willing to Take Substantial Medication Risks for Symptom Relief.
Irritable bowel syndrome (IBS) is a common chronic functional bowel disorder for which patients take significant risks to ameliorate symptoms. Unfortunately, there is no cure for IBS. We assessed the willingness of patients with IBS to take medication risks and the costs they would pay to improve symptoms. Via Clinical Gastroenterology and Hepatology.
Published to PubMed This Week
- A Rare Case of Selective Igκ Chain Deficiency: Biologic and Clinical Implications.
Journal of Allergy and Clinical Immunology
- Implant Sonication Versus Tissue Culture for the Diagnosis of Spinal Implant Infection.
- Pilot Evaluation of Sensitive Data Segmentation Technology for Privacy.
International Journal of Medical Information
- GFAP IgG Associated Inflammatory Polyneuropathy.
Journal of Neuroimmunology
- Alcohol Use is not A Significant Contributor to Myelodysplastic Syndromes.
Cancer Causes and Control
- Amyloid in the Lung.
Seminars in Respiratory Critical Care and Medicine
- Characterizing False-Positive Fluorescence in Situ Hybridization Results by Mate-Pair Sequencing in a Patient with Chronic Myeloid Leukemia and Progression to Myeloid Blast Crisis.
Cancer and Genetics
- Accuracy of Liver and Spleen Stiffness on Magnetic Resonance Elastography for Detecting Portal Hypertension: A Systematic Review and Meta-Analysis.
European Journal of Gastroenterology and Hepatology